ID   KGP_PLABA               Reviewed;         856 AA.
AC   A0A509AKL0;
DT   10-FEB-2021, integrated into UniProtKB/Swiss-Prot.
DT   18-SEP-2019, sequence version 1.
DT   07-APR-2021, entry version 10.
DE   RecName: Full=cGMP-dependent protein kinase {ECO:0000303|PubMed:19779564};
DE            EC=2.7.11.12 {ECO:0000250|UniProtKB:Q8I719};
DE   AltName: Full=PbPKG {ECO:0000303|PubMed:19940133};
GN   Name=PKG {ECO:0000303|PubMed:19779564};
GN   ORFNames=PBANKA_1008200 {ECO:0000312|EMBL:VUC56080.1};
OS   Plasmodium berghei (strain Anka).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Vinckeia).
OX   NCBI_TaxID=5823 {ECO:0000312|Proteomes:UP000074855};
RN   [1] {ECO:0000312|Proteomes:UP000074855}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ANKA {ECO:0000312|Proteomes:UP000074855};
RX   PubMed=25359557; DOI=10.1186/s12915-014-0086-0;
RA   Otto T.D., Bohme U., Jackson A.P., Hunt M., Franke-Fayard B.,
RA   Hoeijmakers W.A., Religa A.A., Robertson L., Sanders M., Ogun S.A.,
RA   Cunningham D., Erhart A., Billker O., Khan S.M., Stunnenberg H.G.,
RA   Langhorne J., Holder A.A., Waters A.P., Newbold C.I., Pain A., Berriman M.,
RA   Janse C.J.;
RT   "A comprehensive evaluation of rodent malaria parasite genomes and gene
RT   expression.";
RL   BMC Biol. 12:86-86(2014).
RN   [2] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=19779564; DOI=10.1371/journal.ppat.1000599;
RA   Moon R.W., Taylor C.J., Bex C., Schepers R., Goulding D., Janse C.J.,
RA   Waters A.P., Baker D.A., Billker O.;
RT   "A cyclic GMP signalling module that regulates gliding motility in a
RT   malaria parasite.";
RL   PLoS Pathog. 5:e1000599-e1000599(2009).
RN   [3] {ECO:0000305}
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=19940133; DOI=10.1074/jbc.m109.070367;
RA   Falae A., Combe A., Amaladoss A., Carvalho T., Menard R., Bhanot P.;
RT   "Role of Plasmodium berghei cGMP-dependent protein kinase in late liver
RT   stage development.";
RL   J. Biol. Chem. 285:3282-3288(2010).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF THR-622.
RX   PubMed=24594931; DOI=10.1371/journal.pbio.1001806;
RA   Brochet M., Collins M.O., Smith T.K., Thompson E., Sebastian S.,
RA   Volkmann K., Schwach F., Chappell L., Gomes A.R., Berriman M., Rayner J.C.,
RA   Baker D.A., Choudhary J., Billker O.;
RT   "Phosphoinositide metabolism links cGMP-dependent protein kinase G to
RT   essential Ca(2+) signals at key decision points in the life cycle of
RT   malaria parasites.";
RL   PLoS Biol. 12:e1001806-e1001806(2014).
RN   [5] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE,
RP   AND MUTAGENESIS OF THR-622.
RX   PubMed=27425827; DOI=10.1111/mmi.13466;
RA   Govindasamy K., Jebiwott S., Jaijyan D.K., Davidow A., Ojo K.K.,
RA   Van Voorhis W.C., Brochet M., Billker O., Bhanot P.;
RT   "Invasion of hepatocytes by Plasmodium sporozoites requires cGMP-dependent
RT   protein kinase and calcium dependent protein kinase 4.";
RL   Mol. Microbiol. 102:349-363(2016).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF THR-622.
RX   PubMed=30315162; DOI=10.1038/s41467-018-06733-w;
RA   Fang H., Gomes A.R., Klages N., Pino P., Maco B., Walker E.M.,
RA   Zenonos Z.A., Angrisano F., Baum J., Doerig C., Baker D.A., Billker O.,
RA   Brochet M.;
RT   "Epistasis studies reveal redundancy among calcium-dependent protein
RT   kinases in motility and invasion of malaria parasites.";
RL   Nat. Commun. 9:4248-4248(2018).
CC   -!- FUNCTION: Serine/threonine protein kinase which acts as a downstream
CC       effector of the second messenger cGMP (By similarity). Controls the
CC       release of Ca(2+) from intracellular stores by regulating
CC       phosphoinositide biosynthesis (PubMed:24594931). Ca(2+) signals are
CC       essential for merozoite and sporozoite invasion and egress from host
CC       hepatocytes and erythrocytes, and, in the mosquito vector, for
CC       gametocyte activation, and ookinete and sporozoite motility
CC       (PubMed:24594931). During the host liver stage, regulates the initial
CC       invasion of host hepatocytes by sporozoites by regulating sporozoite
CC       motility and microneme exocytosis (PubMed:27425827). Following parasite
CC       development in the hepatocytes, required for the release of merosomes,
CC       a vesicle containing the mature merozoites (PubMed:19940133,
CC       PubMed:27425827). During the asexual blood stage, required for the
CC       progression from schizont to the ring stage following merozoite
CC       invasion of host erythrocytes and for merozoite egress (By similarity).
CC       Regulates merozoite egress by promoting the release of exonemes and
CC       micronemes which contain proteins essential for egress (By similarity).
CC       Phosphorylates CDPK1 predominantly at the late schizont stage;
CC       phosphorylation at 'Ser-64' regulates CDPK1 protein-protein interaction
CC       and phosphorylation at 'Thr-231' may regulate CDPK1 kinase activity (By
CC       similarity). In the mosquito vector, required for the initiation of
CC       gametogenesis induced by xanthurenic acid, specifically the gametocyte
CC       differentiation from the crecsent-shaped form to the spherical form
CC       (PubMed:24594931). Required for the gliding motility of ookinetes to
CC       reach and penetrate the midgut epithelium by promoting Ca(2+)-mediated
CC       activation of CDPK1 and CDPK4 (PubMed:19779564, PubMed:24594931,
CC       PubMed:30315162). Also required for microneme secretion in ookinete by
CC       promoting Ca(2+)-mediated activation of CDPK3 (PubMed:30315162).
CC       {ECO:0000250|UniProtKB:Q8I719, ECO:0000269|PubMed:19779564,
CC       ECO:0000269|PubMed:19940133, ECO:0000269|PubMed:24594931,
CC       ECO:0000269|PubMed:27425827, ECO:0000269|PubMed:30315162}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.12;
CC         Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.12; Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- ACTIVITY REGULATION: Activated by cGMP. Not activated by cAMP. cGMP
CC       binding allosterically triggers a conformational change at the alpha C-
CC       helix of cGMP-binding domain 4, which bridges the regulatory and
CC       catalytic domains, causing the capping triad, composed of Arg-488, Gln-
CC       536 and Asp-537, to form and stabilize the active conformation. The
CC       cGMP-binding domains acts cooperatively to activate PKG.
CC       {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19779564,
CC       ECO:0000269|PubMed:27425827}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8I719}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q8I719}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q8I719}. Note=Predominantly localizes to the
CC       cytoplasm during schizogony. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during the parasite blood stage
CC       including gametocytes (PubMed:19779564). Expressed in sporozoites (at
CC       protein level) (PubMed:27425827). Expressed during the parasite liver
CC       stages (at protein level) (PubMed:19940133, PubMed:27425827). In the
CC       mosquito host, expressed in the ookinetes (PubMed:19779564).
CC       {ECO:0000269|PubMed:19779564, ECO:0000269|PubMed:19940133,
CC       ECO:0000269|PubMed:27425827}.
CC   -!- DOMAIN: The cGMP-binding domains 1, 2 and 4 bind preferentially cGMP.
CC       The cGMP-binding domain 4 binds cGMP with the highest affinity and is
CC       highly selective for cGMP. The cGMP-binding domain 3 does not bind cGMP
CC       but is required for cGMP-dependent catalytic activity. The cGMP-binding
CC       domains 1, 2 and 4 can bind cAMP but with less affinity.
CC       {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- DOMAIN: The autoinhibitory segment (AIS) interacts with the active site
CC       and inhibits catalytic activity. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- DISRUPTION PHENOTYPE: Knockout sporozoites can infect their mouse host,
CC       however they fail to develop into erythrocyte stage parasite due to
CC       impaired late liver stage development (PubMed:19940133). Sporozoites
CC       invasion of hepatocytes is normal due to residual expression of PKG
CC       (PubMed:27425827). During the liver stage, the development of
CC       merozoites is normal but the release of merosomes, a vesicle containing
CC       the mature merozoites, is impaired (PubMed:19940133).
CC       {ECO:0000269|PubMed:19940133, ECO:0000269|PubMed:27425827}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cGMP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; LK023125; VUC56080.1; -; Genomic_DNA.
DR   SMR; A0A509AKL0; -.
DR   OMA; ESCLADC; -.
DR   Proteomes; UP000074855; Chromosome 10.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004692; F:cGMP-dependent protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:RHEA.
DR   CDD; cd00038; CAP_ED; 4.
DR   CDD; cd05572; STKc_cGK; 1.
DR   Gene3D; 2.60.120.10; -; 4.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR002374; cGMP_dep_kinase.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR035014; STKc_cGK.
DR   Pfam; PF00027; cNMP_binding; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000559; cGMP-dep_kinase; 1.
DR   SMART; SM00100; cNMP; 4.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF51206; SSF51206; 4.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 3.
DR   PROSITE; PS00889; CNMP_BINDING_2; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 4.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; cGMP; cGMP-binding; Cytoplasm; Endoplasmic reticulum; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..856
FT                   /note="cGMP-dependent protein kinase"
FT                   /id="PRO_0000451910"
FT   DOMAIN          545..802
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          803..856
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   NP_BIND         62..177
FT                   /note="3',5'-cGMP 1; low affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         180..279
FT                   /note="3',5'-cGMP 2; low affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         299..402
FT                   /note="3',5'-cGMP 3; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         422..521
FT                   /note="3',5'-cGMP 4; high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         551..559
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..33
FT                   /note="Autoinhibitory segment"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   ACT_SITE        668
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         574
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            488
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   SITE            536
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   SITE            537
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   MUTAGEN         622
FT                   /note="T->Q: Reduces intracellular Ca(2+) increase in
FT                   response to cGMP during early gametogenesis. Normal asexual
FT                   growth rate, gametocyte and ookinete formation, midgut
FT                   oocyst numbers, salivary gland sporozoite numbers, and
FT                   sporozoite infectivity to mice. In a CDPK4 knockout
FT                   background, reduces ring formation and thus the number of
FT                   schizonts in infected mice. In addition, merozoites have a
FT                   discontinuous inner membrane complex. Also, male
FT                   gametocytes fail to exflagellate in the mosquito vector.
FT                   Resistant to trisubstituted pyrrole compound 1 (C1) and
FT                   imidazopyridine-based compound 2 (C2) inhibitors."
FT                   /evidence="ECO:0000269|PubMed:24594931,
FT                   ECO:0000269|PubMed:30315162"
SQ   SEQUENCE   856 AA;  97901 MW;  5523ACE4F121799D CRC64;
     MDDDEIIPKK NHPSNERNKK KAILSHEDFT GEDSLMENHL ELRDKLTEDI VTIKASLKNN
     LVCSTLNENE ILALSNYMQF FVFKSGDMVI KQGEKGSYFF IINSGKFDVY VNDKKVKTLT
     KGSSFGEAAL IHNTQRSATI KAGTNGTLWG VQRSTFRATL KQLSNRNFNE NRSFIDSVSV
     FDMLTEAQKN MITNACVIQN FKPGETIVKQ GDYGDVLYIL KDGKATVYIN DEEIRVLEKG
     SYFGERALLY DEPRSATIIA KEVTSCASIC RKLLNVVLGN LQVVLFRNIM TEALQQSEIF
     KQISPDQLND LADTAIVRDY PANYNILHKD KIKSVKYIIV LEGKVELFLD DESIGILTRG
     KSFGDQYVLN QKQKFKHTLK SLEVCKIALI TESCLADCLG NNNIDASIDY NNKKSIIKKM
     YIFRYLTDKQ CNLLIEAFKT TRYEEGDYII QEGEVGSRFY IIKAGEVEIV KNNKRLRTLG
     KNDYFGERAL IYDEPRTASV ISTVNNLECW YVDKSVFLQI IEGPMLAHLE ERIKMQDTKV
     EMSELLTERI IGRGTFGIVK LVLHEPTKIR YALKCVSKKS IIELNQQNNI KLEREITAEN
     DHPFIIRLVR TFKDSKYFYF LTELVTGGEL YDAIRKLGLL SRSQAQFYLG SIILAIEYLH
     ERSIVYRDLK PENILLDKQG YVKLIDFGCA KKIHGRSYTL VGTPHYMAPE VILGKGYGCT
     VDIWAFGVCL YEFICGPLPF GNDQEDQLEI FRDILTGQLT FPDYVTDTDS INLIKRLLCR
     LPQGRIGCSI NGFKDIKENS FFADFDWDRL AGRLLEPPLI SKSETYAEDI DVKQIEQEEE
     DNANTEIDDE NWDIDF
//
